東北大学

東北大学大学院医学系研究科
腎・膠原病・内分泌内科学分野
東北大学病院 腎・高血圧・内分泌科

論文・著書

～歴史ある論文・著書～

2021年

論文【英文】

  1. Ogawa S, Ohsaki Y, Shimizu M, Nako K, Okamura M, Kabayama S, Tabata K, Tanaka Y, Ito S. Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial. Diabetol Int. 2021 Jul 18;13(1):209-219. doi: 10.1007/s13340-021-00524-3. eCollection 2022 Jan.
  2. Chiba Y, Takahashi K, Makino R, Yoshida M, Oe Y, Nagasawa T, Sato H, Miyazaki M, Okamoto K. Glomerulonephritis Associated with Infective Endocarditis Showing Serological Positivity for PR3-anti-neutrophil Cytoplasmic Antibody and Anti-glomerular Basement Membrane Antibody. Intern Med. 2022 Jul 15;61(14):2179-2185. doi: 10.2169/internalmedicine.8385-21. Epub 2021 Dec 28.
  3. Ho HJ, Kikuchi K, Oikawa D, Watanabe S, Kanemitsu Y, Saigusa D, Kujirai R, Ikeda-Ohtsubo W, Ichijo M, Akiyama Y, Aoki Y, Mishima E, Ogata Y, Oikawa Y, Matsuhashi T, Toyohara T, Suzuki C, Suzuki T, Mano N, Kagawa Y, Owada Y, Katayama T, Nakayama T, Tomioka Y, Abe T. SGLT-1-specific inhibition ameliorates renal failure and alters the gut microbial community in mice with adenine-induced renal failure. Physiol Rep. 2021 Dec;9(24):e15092. doi: 10.14814/phy2.15092.
  4. Chiba Y, Nagasawa T. Peritubular and Perivascular Amyloid Deposits in Amyloid Nephropathy. Intern Med. 2021;60(24):4001-4002. doi: 10.2169/internalmedicine.7710-21. Epub 2021 Dec 15.
  5. Ogishima S, Nagaie S, Mizuno S, Ishiwata R, Iida K, Shimokawa K, Takai-Igarashi T, Nakamura N, Nagase S, Nakamura T, Tsuchiya N, Nakaya N, Murakami K, Ueno F, Onuma T, Ishikuro M, Obara T, Mugikura S, Tomita H, Uruno A, Kobayashi T, Tsuboi A, Tadaka S, Katsuoka F, Narita A, Sakurai M, Makino S, Tamiya G, Aoki Y, Shimizu R, Motoike IN, Koshiba S, Minegishi N, Kumada K, Nobukuni T, Suzuki K, Danjoh I, Nagami F, Tanno K, Ohmomo H, Asahi K, Shimizu A, Hozawa A, Kuriyama S; Tohoku Medical Megabank Project Study Group, Fuse N, Tominaga T, Kure S, Yaegashi N, Kinoshita K, Sasaki M, Tanaka H, Yamamoto M. dbTMM: an integrated database of large-scale cohort, genome and clinical data for the Tohoku Medical Megabank Project. Hum Genome Var. 2021 Dec 10;8(1):44. doi: 10.1038/s41439-021-00175-5.
  6. Iso H, Cui R, Takamoto I, Kiyama M, Saito I, Okamura T, Miyamoto Y, Higashiyama A, Kiyohara Y, Ninomiya T, Yamada M, Nakagawa H, Sakurai M, Shimabukuro M, Higa M, Shimamoto K, Saito S, Daimon M, Kayama T, Noda M, Ito S, Yokote K, Ito C, Nakao K, Yamauchi T, Kadowaki T. Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort Studies. J Am Heart Assoc. 2021 Dec 7;10(23):e020760. doi: 10.1161/JAHA.121.020760. Epub 2021 Nov 19.
  7. Wada T, Ishimoto T, Nakaya I, Kawaguchi T, Sofue T, Shimizu S, Kurita N, Sasaki S, Nishiwaki H, Koizumi M, Saito S, Nishibori N, Oe Y, Yoshida M, Miyaoka Y, Akiyama S, Itano Y, Okazaki M, Ozeki T, Ichikawa D, Oguchi H, Kohsaka S, Kosaka S, Kataoka Y, Shima H, Shirai S, Sugiyama K, Suzuki T, Son D, Tanaka T, Nango E, Niihata K, Nishijima Y, Nozu K, Hasegawa M, Miyata R, Yazawa M, Yamamoto Y, Yamamoto R, Shibagaki Y, Furuichi K, Okada H, Narita I; Committee of Clinical Practical Guideline for Nephrotic Syndrome 2020. A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020. Clin Exp Nephrol. 2021 Dec;25(12):1277-1285. doi: 10.1007/s10157-021-02098-5. Epub 2021 Sep 26.
  8. Usui J, Kawashima S, Sada KE, Miyawaki Y, Nakazawa D, Itabashi M, Endo S, Endo T, Oda T, Ohya M, Kitagawa K, Nagasawa T, Hirahashi J, Hiromura K, Kawaguchi T, Takayasu M, Tsuboi N, Hirayama K, Muso E, Yumura W, Kaname S, Furuichi K, Okada H, Narita I; Committee of Clinical Practical Guideline for Rapidly Progressive Glomerulonephritis 2020. A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020. Clin Exp Nephrol. 2021 Dec;25(12):1286-1291. doi: 10.1007/s10157-021-02096-7. Epub 2021 Sep 26.
  9. Oe Y, Miyazaki M, Takahashi N. Coagulation, Protease-Activated Receptors, and Diabetic Kidney Disease: Lessons from eNOS-Deficient Mice. Tohoku J Exp Med. 2021 Sep;255(1):1-8. doi: 10.1620/tjem.255.1.
  10. Shindo H, Harada-Shoji N, Ebata A, Sato M, Soga T, Miyashita M, Tada H, Kawai M, Kosaka S, Onuki K, Usami S, Furumoto S, Hayashi S, Abe T, Suzuki T, Ishida T, Sasano H. Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer. Cancers (Basel). 2021 Aug 30;13(17):4375. doi: 10.3390/cancers13174375.
  11. Ubara Y, Kawaguchi T, Nagasawa T, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Tsuruya K; Committee of Practical Guide for Kidney Biopsy 2020. Correction to: Kidney biopsy guidebook 2020 in Japan. Clin Exp Nephrol. 2021 Oct;25(10):1161. doi: 10.1007/s10157-021-02120-w.
  12. Rossi GP, Crimì F, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Christian Rump L, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Cent Wu V, Kratka Z, Barbiero G, Seccia TM, Battistel M. Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic International Study. J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4340-e4349. doi: 10.1210/clinem/dgab482.
  13. Ogata H, Yamazaki Y, Tezuka Y, Gao X, Omata K, Ono Y, Kawasaki Y, Tanaka T, Nagano H, Wada N, Oki Y, Ikeya A, Oki K, Takeda Y, Kometani M, Kageyama K, Terui K, Gomez-Sanchez CE, Liu S, Morimoto R, Joh K, Sato H, Miyazaki M, Ito A, Arai Y, Nakamura Y, Ito S, Satoh F, Sasano H. Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism. Hypertension. 2021 Aug;78(2):411-421. doi: 10.1161/HYPERTENSIONAHA.121.17436. Epub 2021 Jun 14.
  14. Tezuka Y, Ishii K, Zhao L, Yamazaki Y, Morimoto R, Sasano H, Udager AM, Satoh F, Turcu AF. ACTH Stimulation Maximizes the Accuracy of Peripheral Steroid Profiling in Primary Aldosteronism Subtyping. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3969-e3978. doi: 10.1210/clinem/dgab420.
  15. Ito S, Kashihara N, Shikata K, Nangaku M, Wada T, Okuda Y, Sawanobori T. Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study. Clin Exp Nephrol. 2021 Oct;25(10):1070-1078. doi: 10.1007/s10157-021-02075-y. Epub 2021 Jun 10.
  16. Yamakage S, Oe Y, Sato E, Okamoto K, Sekimoto A, Kumakura S, Sato H, Yoshida M, Nagasawa T, Miyazaki M, Ito S, Mackman N, Takahashi N. Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine diet. Sci Rep. 2021 Jun 9;11(1):12159. doi: 10.1038/s41598-021-91586-5.
  17. Akiyama Y, Tomioka Y, Abe T, Anderson P, Ivanov P. In lysate RNA digestion provides insights into the angiogenin's specificity towards transfer RNAs. RNA Biol. 2021 Dec;18(12):2546-2555. doi: 10.1080/15476286.2021.1930758. Epub 2021 Jun 4.
  18. Pieroni J, Yamazaki Y, Gao X, Tezuka Y, Ogata H, Omata K, Ono Y, Morimoto R, Nakamura Y, Satoh F, Sasano H. Cellular Senescence in Human Aldosterone-Producing Adrenocortical Cells and Related Disorders. Biomedicines. 2021 May 18;9(5):567. doi: 10.3390/biomedicines9050567.
  19. Sato T, Maekawa M, Mano N, Abe T, Yamaguchi H. Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19. J Pharm Pharm Sci. 2021;24:227-236. doi: 10.18433/jpps31813.
  20. Shil SK, Kagawa Y, Umaru BA, Nanto-Hara F, Miyazaki H, Yamamoto Y, Kobayashi S, Suzuki C, Abe T, Owada Y. Ndufs4 ablation decreases synaptophysin expression in hippocampus. Sci Rep. 2021 May 26;11(1):10969. doi: 10.1038/s41598-021-90127-4.
  21. Oribe S, Toyohara T, Mishima E, Suzuki T, Kikuchi K, Watanabe S, Morita Y, Ota H, Seiji K, Miyazaki M, Takase K, Abe T. Fibromuscular dysplasia with recurrence after "long-term" following percutaneous transcatheter renal angioplasty: two case reports with a review of 26 patients. BMC Nephrol. 2021 May 20;22(1):187. doi: 10.1186/s12882-021-02342-w.
  22. Fujimaru T, Kawanishi K, Mori T, Mishima E, Sekine A, Chiga M, Mizui M, Sato N, Yanagita M, Ooki Y, Nagahama K, Ohnuki Y, Hamano N, Watanabe S, Mochizuki T, Nagatsuji K, Tanaka K, Tsukamoto T, Tsushima H, Shimamoto M, Tsuji T, Kuyama T, Kawamoto S, Maki K, Katsuma A, Oishi M, Yamamoto K, Mandai S, Kikuchi H, Ando F, Mori Y, Susa K, Iimori S, Naito S, Rai T, Hoshino J, Ubara Y, Miyazaki M, Nagata M, Uchida S, Sohara E. Genetic Background and Clinicopathologic Features of Adult-onset Nephronophthisis. Kidney Int Rep. 2021 Mar 4;6(5):1346-1354. doi: 10.1016/j.ekir.2021.02.005. eCollection 2021 May.
  23. Gao X, Yamazaki Y, Tezuka Y, Omata K, Ono Y, Morimoto R, Nakamura Y, Suzuki T, Satoh F, Sasano H. Pathology of Aldosterone Biosynthesis and its Action. Tohoku J Exp Med. 2021 May;254(1):1-15. doi: 10.1620/tjem.254.1.
  24. Akiyama Y, Kikuchi K, Toyohara T, Mishima E, Suzuki C, Suzuki T, Nakayama M, Tomioka Y, Soga T, Abe T. CE-MS-Based Identification of Uremic Solutes Specific to Hemodialysis Patients. Toxins (Basel). 2021 Apr 30;13(5):324. doi: 10.3390/toxins13050324.
  25. Seki Y, Ishizawa K, Akaishi T, Abe M, Okamoto K, Tanaka J, Arita R, Takayama S, Kikuchi A, Miyazaki M, Harigae H, Sato M, Hoshi M, Hatsugai K, Ishii T. Retrospective study revealed that Zn relate to improvement of swallowing function in the older adults. BMC Geriatr. 2021 Apr 26;21(1):279. doi: 10.1186/s12877-021-02224-8.
  26. Tezuka Y, Turcu AF. Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism. Front Endocrinol (Lausanne). 2021 Mar 26;12:625457. doi: 10.3389/fendo.2021.625457. eCollection 2021.
  27. Oe Y, Mishima E, Mori T, Okamoto K, Honkura Y, Nagasawa T, Yoshida M, Sato H, Suzuki J, Ikeda R, Sohara E, Uchida S, Katori Y, Miyazaki M. A Novel Mutation in LMX1B (p.Pro219Ala) Causes Focal Segmental Glomerulosclerosis with Alport Syndrome-like Phenotype. Intern Med. 2021 Sep 15;60(18):2991-2996. doi: 10.2169/internalmedicine.6987-20. Epub 2021 Apr 5.
  28. Tezuka Y, Yamazaki Y, Nakamura Y, Sasano H, Satoh F. Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review. Biomedicines. 2021 Mar 17;9(3):310. doi: 10.3390/biomedicines9030310.
  29. Watanabe K, Nakayama M, Yamamoto T, Yamada G, Sato H, Miyazaki M, Ito S. Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study. PLoS One. 2021 Mar 25;16(3):e0249240. doi: 10.1371/journal.pone.0249240. eCollection 2021.
  30. Shimatsu A, Nakamura A, Takahashi Y, Fujio S, Satoh F, Tahara S, Nishioka H, Takano K, Yamashita M, Arima H, Tominaga A, Tateishi S, Matsushita Y. Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan. Endocr J. 2021 Jul 28;68(7):791-805. doi: 10.1507/endocrj.EJ20-0707. Epub 2021 Mar 11.
  31. Gao X, Yamazaki Y, Tezuka Y, Omata K, Ono Y, Morimoto R, Nakamura Y, Satoh F, Sasano H. The Genotype-Based Morphology of Aldosterone-Producing Adrenocortical Disorders and Their Association with Aging. Endocrinol Metab (Seoul). 2021 Feb;36(1):12-21. doi: 10.3803/EnM.2021.101. Epub 2021 Feb 24.
  32. Watanabe K, Sato E, Mishima E, Watanabe M, Abe T, Takahashi N, Nakayama M. Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease. Heliyon. 2021 Feb 10;7(2):e06221. doi: 10.1016/j.heliyon.2021.e06221. eCollection 2021 Feb.
  33. Matsunaga H, Tezuka Y, Kinoshita T, Ogata H, Yamazaki Y, Shiratori B, Omata K, Ono Y, Morimoto R, Kudo M, Seiji K, Takase K, Kawasaki Y, Ito A, Sasano H, Harigae H, Satoh F. The Potential of Computed Tomography Volumetry for the Surgical Treatment in Bilateral Macronodular Adrenal Hyperplasia: A Case Report. Tohoku J Exp Med. 2021 Feb;253(2):143-150. doi: 10.1620/tjem.253.143.
  34. Saeki T, Kawano M, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Hisano S, Yamaguchi Y, Nomura H, Saito T, Nakashima H. Correction to: Validation of the diagnostic criteria for IgG4‑related kidney disease (IgG4‑RKD) 2011, and proposal of a new 2020 version. Clin Exp Nephrol. 2021 Apr;25(4):443-444. doi: 10.1007/s10157-021-02040-9.
  35. Saeki T, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Yamaguchi Y, Saito T, Nakashima H, Kawano M. Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese kidney disease cohort: a multicentre retrospective study by the IgG4-related kidney disease working group of the Japanese Society of Nephrology. Ann Rheum Dis. 2021 Jul;80(7):956-957. doi: 10.1136/annrheumdis-2020-219510. Epub 2021 Feb 23.
  36. Ubara Y, Kawaguchi T, Nagasawa T, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Tsuruya K; Committee of Practical Guide for Kidney Biopsy 2020. Kidney biopsy guidebook 2020 in Japan. Clin Exp Nephrol. 2021 Apr;25(4):325-364. doi: 10.1007/s10157-020-01986-6.
  37. Gao X, Yamazaki Y, Tezuka Y, Omata K, Ono Y, Morimoto R, Nakamura Y, Satoh F, Sasano H. Gender differences in human adrenal cortex and its disorders. Mol Cell Endocrinol. 2021 Apr 15;526:111177. doi: 10.1016/j.mce.2021.111177. Epub 2021 Feb 11.
  38. Maruyama Y, Nakayama M, Ueda A, Miyazaki M, Yokoo T. Comparisons of fatigue between dialysis modalities: A cross-sectional study. PLoS One. 2021 Feb 10;16(2):e0246890. doi: 10.1371/journal.pone.0246890. eCollection 2021.
  39. Tezuka Y, Atsumi N, Blinder AR, Rege J, Giordano TJ, Rainey WE, Turcu AF. The Age-Dependent Changes of the Human Adrenal Cortical Zones Are Not Congruent. J Clin Endocrinol Metab. 2021 Apr 23;106(5):1389-1397. doi: 10.1210/clinem/dgab007.
  40. Miyauchi K, Nakai T, Saito S, Yamamoto T, Sato K, Kato K, Nezu M, Miyazaki M, Ito S, Yamamoto M, Suzuki N. Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions. EBioMedicine. 2021 Feb;64:103209. doi: 10.1016/j.ebiom.2021.103209. Epub 2021 Jan 25.
  41. Kumakura S, Sato E, Sekimoto A, Hashizume Y, Yamakage S, Miyazaki M, Ito S, Harigae H, Takahashi N. Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease. Toxins (Basel). 2021 Jan 11;13(1):50. doi: 10.3390/toxins13010050.
  42. Sato M, Harada-Shoji N, Toyohara T, Soga T, Itoh M, Miyashita M, Tada H, Amari M, Anzai N, Furumoto S, Abe T, Suzuki T, Ishida T, Sasano H. L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism. Sci Rep. 2021 Jan 12;11(1):589. doi: 10.1038/s41598-020-80668-5.
  43. Chiba Y, Nagasawa T, Kin S, Takahashi K, Yoshida M, Oe Y, Okamoto K, Sato H, Miyazaki M. Spontaneous remission of minimal change nephrotic syndrome in an elderly man. CEN Case Rep. 2021 May;10(2):301-307. doi: 10.1007/s13730-020-00554-x. Epub 2021 Jan 4.
  44. Saeki T, Kawano M, Nagasawa T, Ubara Y, Taniguchi Y, Yanagita M, Nishi S, Nagata M, Hisano S, Yamaguchi Y, Nomura H, Saito T, Nakashima H. Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version. Clin Exp Nephrol. 2021 Feb;25(2):99-109. doi: 10.1007/s10157-020-01993-7. Epub 2021 Jan 4.
  45. Ito S, Itoh H, Rakugi H, Okuda Y, Iijima S. Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction. Hypertens Res. 2021 May;44(5):489-497. doi: 10.1038/s41440-020-00585-y. Epub 2020 Dec 16.
  46. Higuchi S, Ota H, Tezuka Y, Seiji K, Takagi H, Lee J, Lee YW, Omata K, Ono Y, Morimoto R, Kudo M, Satoh F, Takase K. Aldosterone-induced cardiac damage in primary aldosteronism depends on its subtypes. Endocr Connect. 2021 Jan;10(1):29-36. doi: 10.1530/EC-20-0504.
  47. Satoh F, Ito S, Itoh H, Rakugi H, Shibata H, Ichihara A, Omura M, Takahashi K, Okuda Y, Iijima S. Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism. Hypertens Res. 2021 Apr;44(4):464-472. doi: 10.1038/s41440-020-00570-5. Epub 2020 Nov 16.
  48. Kario K, Ito S, Itoh H, Rakugi H, Okuda Y, Yoshimura M, Yamakawa S. Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study. Am J Hypertens. 2021 May 22;34(5):540-551. doi: 10.1093/ajh/hpaa155.
  49. Oe Y, Mitsui S, Sato E, Shibata N, Kisu K, Sekimoto A, Miyazaki M, Sato H, Ito S, Takahashi N. Lack of Endothelial Nitric Oxide Synthase Accelerates Ectopic Calcification in Uremic Mice Fed an Adenine and High Phosphorus Diet. Am J Pathol. 2021 Feb;191(2):283-293. doi: 10.1016/j.ajpath.2020.10.012. Epub 2020 Nov 4.
  50. Wada T, Hara A, Muso E, Maruyama S, Kato S, Furuichi K, Yoshimura K, Toyama T, Sakai N, Suzuki H, Tsukamoto T, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Goto S, Sakamaki Y, Yokoyama H, Mori N, Tanaka S, Yuzawa Y, Hasegawa M, Matsubara T, Wada J, Tanabe K, Masutani K, Abe Y, Tsuruya K, Fujimoto S, Iwatsubo S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Sofue T, Miyata H, Nakano T, Ohtake T, Kobayashi S; LICENSE study Group. Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia. Clin Exp Nephrol. 2021 Jan;25(1):1-8. doi: 10.1007/s10157-020-01959-9. Epub 2020 Aug 28.
  51. Sasaki Y, Mishima E, Kikuchi K, Toyohara T, Suzuki T, Ota H, Seiji K, Miyazaki M, Harigae H, Ito S, Takase K, Abe T. Treatment of Refractory Hypertension with Timely Angioplasty in Total Renal Artery Occlusion with Atrophic Kidney. Intern Med. 2021 Jan 15;60(2):287-292. doi: 10.2169/internalmedicine.5290-20. Epub 2020 Aug 22.
  52. Mishima E, Funayama Y, Suzuki T, Mishima F, Nitta F, Toyohara T, Kikuchi K, Kunikata H, Hashimoto J, Miyazaki M, Harigae H, Nakazawa T, Ito S, Abe T. Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria. Hypertens Res. 2021 Jan;44(1):88-97. doi: 10.1038/s41440-020-0521-2. Epub 2020 Jul 27.
  53. Williams TA, Gomez-Sanchez CE, Rainey WE, Giordano TJ, Lam AK, Marker A, Mete O, Yamazaki Y, Zerbini MCN, Beuschlein F, Satoh F, Burrello J, Schneider H, Lenders JWM, Mulatero P, Castellano I, Knösel T, Papotti M, Saeger W, Sasano H, Reincke M. International Histopathology Consensus for Unilateral Primary Aldosteronism. J Clin Endocrinol Metab. 2021 Jan 1;106(1):42-54. doi: 10.1210/clinem/dgaa484.
  54. Hozawa A, Tanno K, Nakaya N, Nakamura T, Tsuchiya N, Hirata T, Narita A, Kogure M, Nochioka K, Sasaki R, Takanashi N, Otsuka K, Sakata K, Kuriyama S, Kikuya M, Tanabe O, Sugawara J, Suzuki K, Suzuki Y, Kodama EN, Fuse N, Kiyomoto H, Tomita H, Uruno A, Hamanaka Y, Metoki H, Ishikuro M, Obara T, Kobayashi T, Kitatani K, Takai-Igarashi T, Ogishima S, Satoh M, Ohmomo H, Tsuboi A, Egawa S, Ishii T, Ito K, Ito S, Taki Y, Minegishi N, Ishii N, Nagasaki M, Igarashi K, Koshiba S, Shimizu R, Tamiya G, Nakayama K, Motohashi H, Yasuda J, Shimizu A, Hachiya T, Shiwa Y, Tominaga T, Tanaka H, Oyama K, Tanaka R, Kawame H, Fukushima A, Ishigaki Y, Tokutomi T, Osumi N, Kobayashi T, Nagami F, Hashizume H, Arai T, Kawaguchi Y, Higuchi S, Sakaida M, Endo R, Nishizuka S, Tsuji I, Hitomi J, Nakamura M, Ogasawara K, Yaegashi N, Kinoshita K, Kure S, Sakai A, Kobayashi S, Sobue K, Sasaki M, Yamamoto M. Study Profile of the Tohoku Medical Megabank Community-Based Cohort Study. J Epidemiol. 2021 Jan 5;31(1):65-76. doi: 10.2188/jea.JE20190271. Epub 2020 Jan 11.

論文【邦文】

  1. 阿部高明：【慢性腎臓病-臨床の最新動向-】基礎研究　ミトコンドリア創薬と先制医療；日本臨床 79巻12号 1827-1835
  2. 千葉祐貴、吉田舞、林明澄、秋保真穂、長澤将、佐野晃俊、井上淳、市川聡、佐藤博、宮崎真理子：多彩な臨床像を呈したサルコイドーシスの1例；日本内科学会雑誌 110巻10号 2262-2267
  3. 菊地晃一、阿部高明：【糖尿病性腎臓病(DKD)】DKDの基礎　腸内細菌；腎と透析 91巻4号 580-585
  4. 豊原敬文：【裏づけ・つなげ・理解する!病態生理からひもとく水・電解質異常】(第4章)疾患における水・電解質異常　腎不全でみられる水・電解質異常；看護技術 67巻12号 1291-1296
  5. 豊原敬文：【裏づけ・つなげ・理解する!病態生理からひもとく水・電解質異常】(第5章)現場で使える水・電解質異常のトピック　腎不全で起きるカルシウム・リン代謝異常；看護技術 67巻12号 1351-1355
  6. 手塚雄太、岡本好司：【意外と知られていない!?　自科の常識・他科の非常識】(第10章)内分泌　骨粗鬆症治療に重要な活性型ビタミンD製剤は高カルシウム血症クリーゼをきたすこともある；内科 128巻3号 707-710
  7. 宮崎真理子：【透析医療における災害対策】大規模地震・津波；臨床透析 37巻8号 737-742
  8. 宮崎真理子、藤倉恵美、中西慶江、佐々木俊一、小松亜紀、小林淳、家入珠樹、八島友美：【透析医療と災害対策】透析施設での災害対策　災害時の透析医療継続を規定するリスク管理；腎と透析 91巻2号 219-224
  9. 阿部高明：【腎臓と老化】腎臓と老化　ミトコンドリアから；アンチ・エイジング医学 17巻4号 324-329
  10. 千葉祐貴、藤倉恵美、福士泰夫、小野田祥人、久志本成樹、宮崎真理子：突然の背部痛と下肢麻痺を認めた維持血液透析患者の1例；臨床透析 37巻7号 701-708
  11. 長澤将：【CKD・薬剤性腎障害・特殊な患者背景への実践的アプローチ!腎臓病薬物療法コンサルテーション】(第3章)症例に学ぶ!薬剤性腎障害の判断と対応　ナトリウム濃度異常；薬事 63巻10号 1996-2001
  12. 鈴木健弘、阿部高明：ミトコンドリア病とその治療薬開発に向けて　ミトコンドリア創薬の基礎研究と臨床応用；化学と生物 59巻7号 339-344
  13. 三澤計治、三島英換、長谷川嵩矩、大内基司、小島要、河合洋介、松尾雅文、安西尚彦、長崎正朗：まれな変異に重点を置いた尿酸値の遺伝率の研究；痛風と尿酸・核酸 45巻1号 23-30
  14. 三島英換：腎臓内科学　フェロトーシスを標的とした急性腎障害の治療薬の探索；医学のあゆみ 277巻12号 1061-1062
  15. 菊地晃一、阿部高明：【心腎連関から考える2型糖尿病の治療戦略～SGLT2阻害薬を中心に～】腸内細菌叢と心腎連関；月刊糖尿病13巻5号 80-86
  16. 佐藤文俊：治療法の再整理とアップデートのために　専門家による私の治療　原発性アルドステロン症；日本医事新報 5066号 41-42
  17. 佐藤文俊：治療法の再整理とアップデートのために　専門家による私の治療　二次性高血圧症；日本医事新報 5064号 34-36
  18. 鈴木健弘、阿部高明：【腎臓と免疫】腸管免疫・腸内細菌叢と腎臓病；日本腎臓学会誌 63巻3号 244-249
  19. 岡本好司、牧野塁、大江佑治、宮崎真理子：【新人スタッフの「知りたい」にサクッと答える!透析療法&看護のギモン88アンサーブック】(第1章)腎臓のはたらきと透析患者のからだ；透析ケア 2021夏季増刊 12-33
  20. 豊原敬文、阿部高明：基礎研究　4.糖尿病患者由来のiPS細胞を用いた動脈硬化抑制因子の発見；糖尿病学2021 診断と治療社 33-40
  21. 菊地晃一、阿部高明：腸内細菌と腎不全；日本透析医会雑誌 36巻1号 107-113
  22. 佐藤恵美子、阿部高明：【サルコペニア・フレイルの栄養療法・運動療法】CKD存在下のサルコペニア・フレイルの栄養療法・運動療法　CKDによる腸内環境不全時の尿毒素蓄積によるサルコペニアと吸着薬；腎と透析 90巻3号 428-434
  23. 菊地晃一、阿部高明：腎臓内科学　便秘薬による腎臓病の進行抑制と心血管疾患予防の可能性；医学のあゆみ 276巻3号 232-233
  24. 宮崎真理子、宮内健一郎、佐藤浩司、鈴木教郎：【腎性貧血治療のこれまでと,その新しい展開】腎性貧血の発症機序；臨床透析 37巻1号 13-18
  25. 鈴木健弘、阿部高明：最先端医療の今　ミトコンドリア機能改善薬によるミトコンドリア異常症の治療　臨床治験に向けて；Medical Science Digest 47巻1号 54-57

著書【編集・監修・単独執筆】

  1. 長澤将：Dr.長澤の腎臓内科外来実況中継；中外医学社 2021年3月
  2. 長澤将：この局面にこの一手! Dr.長澤直伝! 腎臓病薬物療法の定跡；金芳堂 2021年8月
TOP